Insights into Antidepressant Prescribing Using Open Health Data by Cleland, Brian et al.
1 
Insights into Antidepressant Prescribing Using Open Health Data 
Brian Cleland1, Jonathan Wallace1, Raymond Bond1, Michaela Black2, Maurice 
Mulvenna1, Deborah Rankin2 and Austin Tanney3 
1 Ulster University, Jordanstown Campus, Northern Ireland, UK 
2 Ulster University, Magee Campus, Northern Ireland, UK 
{b.cleland, jg.wallace, rb.bond, mm.black, md.mulvenna}@ulster.ac.uk 
3 Analytics Engines, 1 Chlorine Gardens, Belfast, Northern Ireland, UK  
a.tanney@analyticsengines.com 
Abstract. The growth of big data is transforming many economic sectors, including the 
medical and healthcare sector. Despite this, research into the practical application of data 
analytics to the development of health policy is still limited. In this study we examine how 
data science and machine learning methods can be applied to a variety of open health 
datasets, including GP prescribing data, disease prevalence data and economic deprivation 
data. This paper discusses the context of mental health and antidepressant prescribing in 
Northern Ireland and highlights its importance as a public policy issue. A hypothesis is 
proposed, suggesting that the link between antidepressant usage and economic deprivation is 
mediated by depression prevalence. An analysis of various heterogeneous open datasets is 
used to test this hypothesis. A description of the methodology is provided, including the open 
health datasets under investigation and an explanation of the data processing pipeline. 
Correlations between key variables and several different clustering analyses are presented. 
Evidence is provided which suggests that the depression prevalence hypothesis is flawed. 
Clusters of GP practices based on prescribing behaviour and disease prevalence are described 
and key characteristics are identified and discussed. Possible policy implications are explored 
and opportunities for future research are identified. 
Keywords: Health Policy, Data Analytics, Big Data, Prescribing, Prevalence, Machine 
learning, Deprivation. 
1 Introduction 
As the influence of data science has grown across industry and society, so the term 
“big data” has become widely used to describe the phenomenon. Every economic 
sector has been affected by this trend, and healthcare is no exception [1, 30, 17]. 
Governments worldwide have begun to include the impact of big data in their policy 
statements. The UK government recently stated that big data had “huge unrealised 
potential, both as a driver of productivity and as a way of offering better products 
and services to citizens” [15]. Despite this, research on the implications of big data to 
medical policymaking and service delivery remains relatively limited. With the 
exception of some public health surveillance [31, 5] and pharmacovigilance systems 
[33], the opportunities for better policymaking using big data are still largely 
unexplored. 
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In this study we provide an analysis of the potential application of big data and 
machine learning methods to the development of public policy and service delivery. 
In particular, we focus on the use of heterogenous open data from a variety of online 
sources, including disease prevalence data, GP prescribing data and economic 
deprivation data. We examine how such datasets can be brought together and 
analysed in such as way as to generate usable, actionable insights for clinicians, 
policymakers and the general public. 
2 Related Work 
2.1 Mental Health Policy in Northern Ireland  
In Northern Ireland, as in other parts of the UK [27], mental health has been 
identified as a priority policy area for service provision. In a report produced for the 
Northern Ireland Assembly, Betts and Thompson [4] state that mental illness is the 
single largest cause of ill health and disability. They note that 318 suicides were 
registered in NI during 2015, the highest since records began in 1970 and a 19% 
increase on the suicides recorded in 2014. The report refers to calls for a ten-year 
regional mental health strategy and a mental health champion to lead work across 
government departments. Specific policy challenges identified by the authors 
include the need for more personalised models of care, the need to address stigmas 
around mental health, improved access to services and more GP training. The study 
also notes that Northern Ireland is also lagging in the provision of psychological 
therapies such as psychotherapy, cognitive behavioural therapy (CBT), and trauma 
therapy. 
 
Various factors particularly impact mental health policy in Northern Ireland. 
According to the government figures, Northern Ireland has a 25% higher prevalence 
of mental illness compared to England. It also has lower levels of public spending on 
health services, with health services accounting for 19.7% of the public budget, in 
comparison with 22% in England, 20.4% in Scotland, and 20.3% in Wales [24]. The 
region experiences higher levels of suicide - according to Office of National Statistics 
figures, suicide rates are 16.4 per 100,000 population, whereas the equivalent rates 
in England, Wales and Scotland are 10.3, 9.2 and 15.4 respectively. Mental health-
related issues in Northern Ireland may be due at least in part to the historical conflict 
[3, 6]. Finally, the number of economically inactive adults is 28.4% - 5% above the UK 
average [28]. 
2.2 Antidepressant Prescribing in Northern Ireland 
In a report on mental health in Northern Ireland, the Mental Health Foundation [24] 
states that “according to prescribing trends, Northern Ireland has significantly higher 
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levels of depression than the rest of the UK.” This statement assumes that 
prescribing data can be used as an indicator for underlying health phenomena, and 
more specifically, that antidepressant prescribing in particular reflects levels of 
depression in the wider population. This use of prescribing data as a proxy variable 
for the prevalence of mental illness is not limited to this particular report.  
 
Another example of this assumption being adopted is a pair of studies looking at 
mental health impacts and burdens in Northern Ireland using administrative data 
[20, 21]. In these analyses, prescribing and other forms of administrative data, such 
as social and economic indicators and life event data, are used to determine the 
effect on mental health of factors such as deprivation, bereavement, care-giving and 
transition into care. Findings from these studies suggest that the impact on the 
mental health of individuals of such circumstances are very significant. The authors 
also found that prescribing rates varied widely between GP practices, although they 
speculate that this might be explained by differences in practice population 
composition or levels of deprivation in the practice area.  
 
Another interesting, non-academic, analysis of the same subject using similar data 
sources was published by the Detail Data [22]. This data journalism piece points out 
that compared with a major international study by the OECD, antidepressant usage 
in Northern Ireland is significantly higher than any of the 23 countries surveyed [22]. 
Antidepressant prescription rates in Northern Ireland stand at 129 daily doses per 
thousand, compared with the overall UK figure of 72 daily doses per thousand. The 
authors also demonstrate that there was a strong correlation between economic 
deprivation and levels of antidepressant usage. Interestingly, their analysis shows 
that depression prevalence is not correlated with either economic deprivation or 
antidepressant prescribing. When asked what factors might be behind increasing 
levels of antidepressant prescribing, GPs point to growing public awareness and 
patient demand as a driver.  
2.3 Summary of Policy Context 
Looking at mental health in Northern Ireland, it is clear that the region has important 
challenges in this area, and there are some very specific political, social and 
economic factors that must be taken into account. The burden of mental health 
issues in Northern Ireland is significantly greater than in other parts of the UK. While 
the region experiences higher rates of suicide and illnesses such as depression and 
anxiety, it is also faced with lower levels of public spending on health compared to 
other parts of the UK. There has been some use of administrative data to try to 
understand the policy implications of issues in Northern Ireland. Such studies have 
attempted to illustrate the impact of factors such as economic deprivation and 
bereavement on illnesses such as depression and anxiety. In some of these studies 
prescribing rates have been used as a proxy variable for mental health issues. There 
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is some evidence, however, that the link between prescribing and prevalence is not 
straightforward.  
3 Materials and Methods 
3.1 Hypothesis: Depression Prevalence as a Mediating Factor Between 
Economic Deprivation and Antidepressant Prescribing 
Much of the literature on the use of prescribing data as a proxy for public health 
suggests that the correlation between disease prevalence and prescribing is 
sufficiently strong to make such analyses useful in the development of public policy 
[12, 14]. Based on this assumption, a number of studies have examined the 
correlation between economic deprivation and prescribing and used this to propose 
that economic factors have a measurable impact on mental health. We argue that 
these studies contain an implicit assumption that depression prevalence is a 
mediating factor in the relationship between economic deprivation and 
antidepressant prescribing (see Fig. 1). There is, however, some evidence that the 
link between disease prevalence and prescribing levels is not straightforward or 
reliable [19].  
 
Fig. 1. Hypothesis: mental health is a mediating factor linking economic deprivation and 
antidepressant prescribing (arrows indicate mediating relationships). 
In this study, we tested the hypothesis presented in Fig. 1 by using open data drawn 
from multiple publicly available sources. Specifically, we examined the links between 
three major variables - economic deprivation, depression prevalence and 
antidepressant prescribing - in order to explore the correlations between them. We 
also examined correlations between these variables and other disease prevalence 
data, and with GP prescribing data for other drug groups. Finally, we applied a k-
means clustering algorithm to determine if meaningful GP practice sub-groups could 
be identified from the overall dataset. 
3.2 Open Health Datasets 
GP Prescribing Data 
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Antidepressant prescribing data was downloaded from the Open Data NI portal [37], 
operated by the Northern Ireland Department of Finance. For the purposes of this 
study, data for the twelve months of 2016 was used. In order to provide a direct 
comparison with international figures, it was necessary to classify the data according 
to the international Anatomical Therapeutic Chemical (ATC) Classification System 
[45]. Since UK prescribing data is encoded using the British National Foundry (BNF) 
standard, each drug had to be re-classified. This was done using a dataset provided 
by NHS Dictionary of Medicines and Devices (dm+d) [33]. Classifying the data 
according to the ATC system also allowed prescribing levels to be compared across 
different drugs. This was done using a “defined daily dose” (DDD), defined by the 
World Health Organisation as “the assumed average maintenance dose per day for a 
drug used for its main indication in adults” [45]. Due to some gaps in the NHS dm+d 
data, only chapters 1-10 of the BNF system could be meaningfully analysed in this 
study. 
Economic Deprivation Data 
The metric for economic deprivation used in this study was the Multiple Deprivation 
Measure (MDM), which is published by the Northern Ireland Statistics and Research 
Agency (NISRA) [34]. Unlike in other parts of the UK, individual GP practice data does 
not include deprivation measures. In order to link GP practices to the MDM data, the 
postcode for each practice was obtained from the Detail Data portal [10], an open 
data resource provided by the Northern Ireland Council for Voluntary Action. The 
online MySociety Mapit service [31] was then used to convert the postcode data into 
super output areas (SOA). By linking each practice to a specific SOA we could then 
assign a deprivation measure for each prescriber, based on the data supplied by 
NISRA [34]. While deprivation measures are available for other geographic 
boundaries, super output areas were chosen due to their relatively high granularity 
and stability compared to other boundaries such as electoral wards. 
Disease Prevalence Data 
Disease prevalence data, that is the number of patients per 1000 diagnosed as 
suffering from different diseases, is available across most of the UK under the 
Quality Outcomes Framework (QOF), a collection of data which is designed to 
measure GP performance in order to support GP payments. In Northern Ireland the 
QOF data no longer includes disease prevalence figures, but fortunately these are 
still published separately by the Department of Health [15]. Since the prevalence 
data is linked directly to GP practice identifiers, it allows for a direct comparison 
between the number of patients being diagnosed with depression and the amount 
of antidepressants being prescribed.  
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3.3 Analytics Tools and Pipeline 
Jupyter Notebooks [20] were used to algorithmically restructure, transform and 
merge datasets were required. Pandas [38] and NumPy [35] were used for the 
statistical analysis. Visualisation of the data was also done through Jupyter 
Notebooks using MatPlotLib [41] and Seaborn [42] for charts and graphs and 
iPyLeaflet [19] for maps. Correlations between the key variables were explored using 
the Pearson correlations and p-values. The scikit-learn library [41] was employed to 
perform K-means clustering on the data. 
 
Two major challenges were addressed in the creation of the data pipeline. The first 
was identifying the defined daily dosage (DDD) for each drug in the GP prescribing 
datasets. This was required so that prescribing patterns could be meaningfully 
compared across GP practices. In order to do this, the BNF codes used by the UK 
authorities had to be linked to the World Health Organisation’s ATC classification 
system, since only the latter provides standardised DDD data. After some searching 
it was discovered that the NHS Business Services Authority had created a table or 
correspondences between BNF and ATC codes for its own use, and that this table 
was available as open data from their website.  
 
The second challenge was assigning economic deprivation measures to the individual 
GP practices. Unlike in the rest of the UK, GP practice data does not include this 
information. This problem was resolved by using practice data to interrogate the 
online Mapit service (provided by the not-for-profit MySociety organisation), which 
allowed a Special Output Area (SOA) to be assigned to each practice. These SOAs 
were then matched to the economic deprivation data from NISRA to allocate a 
multiple deprivation measure (mdm) to each practice.   
 
The resulting data pipeline is outlined in Fig. 2. 
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Fig. 2. Data flow diagram illustrating the main data sources and data processing activities. 
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3.4 Results 
Variation in Prescribing Patterns Across GP Practices 
 
Fig. 3. Box plot illustrating variations in prescribing behaviour across GP practices. 
 
Prescribing behaviour for all GP Practices was analysed according to how many 
defined daily doses were prescribed by each practice per patient per month, 
grouped by BNF chapter. Prescribing levels for each drug type were then visualised 
on a box plot (Fig. 3). As can be seen from the diagram, the most heavily prescribed 
drugs are those for central nervous system disorders (including antidepressants), 
infections, and endocrine systems disorders (including insulin). Large variations in 
prescribing are visible across almost all drug categories. Central nervous system 
prescribing (including antidepressants) has a noticeable right-skew, suggesting that a 
relatively small proportion of GPs are prescribing unusually high levels of these 
medicines. 
Variation in Disease Prevalence Across GP Practices 
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Fig. 4. Box plot illustrating variations in disease prevalence across GP practices. 
 
A boxplot (Fig. 4) was also used to illustrate the variation in disease prevalence 
across all GP practices in Northern Ireland. As might be expected, the most visible  
variations appear in the diagnosis of more prevalent disease categories, such as 
depression, hypertension, asthma and diabetes. Both depression and diabetes have 
a noticeable right-skew, suggesting that there are a relatively small number of 
practices with particularly high prevalences of those diseases.  
Correlation Between Antidepressants, Deprivation and Other Prescribing 
A matrix was calculated showing the Pearson correlations between multiple 
measures of deprivation (mdm), the defined daily doses per patient of 
antidepressants (ddd_per_patient) and prescribing levels for other drug groups 
based on BNF chapter. These values were then visualised in a heatmap (Fig. 5). Key 
correlations with economic deprivation and antidepressant prescribing are described 
briefly below.  
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Fig. 5. Heat map showing correlations between economic deprivation (mdm), antidepressant 
prescribing (ddd_per_patient), and other drug prescribing according to BNF chapter. 
 
Economic deprivation and other prescribing: Economic deprivation was strongly 
correlated with central nervous system prescribing (r=0.34) and moderately 
correlated endocrine system prescribing (r=0.24). 
 
Antidepressant prescribing and other prescribing: Antidepressant prescribing was 
strongly correlated with central nervous system prescribing (r=0.54) and endocrine 
prescribing (r=0.31). It was also moderately correlated with prescribing for 
cardiovascular (r=0.25), infections (r=0.29), obstetrics (r=0.29) and musculoskeletal 
(0.29). 
Correlation Between Antidepressants, Deprivation and Other Diseases 
A second matrix was generated showing the relationships between multiple 
measures of deprivation (mdm), the defined daily doses per patient of 
antidepressants (ddd_per_patient) and disease prevalences for all practices. Once 
again, a heatmap was used to visualise the results (Fig. 6). Brief descriptions of the 
findings are given below. 
11 
11 
 
Fig. 6. Heat map showing correlations between economic deprivation (mdm), antidepressant 
prescribing (ddd_per_patient), and other disease prevalences. 
Antidepressant prescribing and economic deprivation: There was strong correlation 
(r=0.51) between levels of antidepressant prescribing and the multiple deprivation 
measure for each practice.  
 
Depression prevalence and economic deprivation: There was a weak correlation 
(r=0.12) between the prevalence of depression among patients of a given GP 
practice and the multiple deprivation measure for the area in which the practice 
resides. 
 
Depression prevalence and antidepressant prescribing: There was a weak 
correlation (r=0.15) between the prevalence of depression among patients of a given 
GP practice and the multiple deprivation measure for the area in which the practice 
resides. 
 
Economic deprivation and other disease prevalences: Economic deprivation was 
particularly strongly correlated with chronic obstructive pulmonary disease (r=0.51) 
and mental health (r=0.31) prevalence. 
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Antidepressant prescribing and other diseases: Antidepressant prescribing was 
particularly strongly correlated with asthma (r=0.34), chronic obstructive pulmonary 
disease (r=0.59), diabetes (r=0.34) and mental health prevalence (r=0.37). 
Clustering GP Practices Based on Prescribing Patterns  
GP practices were clustered using a k-means algorithm [9], based on the prescribing 
patterns according to the defined daily dosage (DDD) per patient per month for each 
BNF chapter group. The default stopping criterion for the scikit-learn library [41] was 
used, which tests for convergence within a predetermined tolerance. The whitening 
algorithm from the scikit-learn library was also used to pre-process the data before 
clustering [9]. The “elbow method” [9] was applied to determine a suitable number 
of clusters for the analysis (see Fig. 7). According to this criterion, a two-cluster and 
three-cluster analysis of the data were undertaken.  
 
The mean feature values for the two-cluster analysis can be viewed in Fig. 8, where 
each line represents the features of a cluster centroid. It can be seen from the chart 
that the cluster A is differentiated by a higher level of economic deprivation (mdm) 
and higher levels of prescribing across all BNF chapters, with the exception of 
“Malignant Disease”. The results of the three-cluster analysis are visible in Fig. 9. 
Cluster C (the “deprived practices”), perhaps unsurprisingly, shows higher levels of 
prescribing across all categories except “Malignant Disease”. Clusters A and B (the 
“non-deprived practices”) show significant differences in prescribing levels, with 
cluster A being higher in every category. 
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Fig. 7. Elbow criterion plot for clusters based on GP prescribing patterns. 
 
Fig. 8. Line chart illustrating the mean feature values for each cluster based on a two-cluster 
analysis of GP prescribing patterns. 
 
Fig. 9. Line chart illustrating the mean feature values for each cluster based on a three-cluster 
analysis of GP prescribing patterns. 
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Clustering GP Practices Based on Disease Prevalence  
GP practices were also clustered based on disease prevalence according to data from 
the NI Department of Health Quality Outcomes Framework. The data was once again 
whitened, and the “elbow method” was used to determine a suitable number of 
clusters for the analysis (see Fig. 10). This time, a two-cluster and four-cluster 
analysis of the data were undertaken. 
 
Fig. 11 shows the mean feature values for each cluster for the two-cluster analysis, 
with each line illustrating the features of a cluster centroid. It can be seen from this 
visualisation that the two clusters are have similar levels of deprivation (mdm), but 
that cluster A has significantly higher disease prevalence levels across all categories 
compared to cluster B. The difference is particularly pronounced in both dementia 
and palliative care, perhaps suggesting an age difference among patients between 
the clusters. 
 
The four-cluster analysis (Fig. 12) reveals some other interesting characteristics. 
Cluster C (the “deprived practices”) has higher economic deprivation levels and 
medium levels of prevalence for most diseases. Clusters A, C and D (the “non-
deprived practices”) show a range of disease prevalence across all the categories. 
The most interesting divergence is between cluster B, which has low deprivation and 
relatively low disease prevalence across the board, and cluster D, which also has a 
low deprivation score, but much higher prevalence for almost all disease categories. 
 
 
 
Fig. 10. Elbow criterion plot for clusters based on disease prevalences. 
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Fig. 11. Line chart illustrating the mean feature values for each cluster based on a two-cluster 
analysis of disease prevalences. 
 
 
Fig. 12. Line chart illustrating the mean feature values for each cluster based on a four-cluster 
analysis of disease prevalences. 
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4 Discussion 
4.1 Summary of the Main Findings 
The issue of relatively greater incidence of mental health issues in Northern Ireland 
compared to other parts of the UK remains an important public health challenge in 
the region. Numerous studies have pointed to a range of factors that might be 
impacting the prevalence of such illnesses. Some studies have noted the higher 
levels of antidepressant prescribing compared to other countries and have 
suggested that there is a link between such prescribing rates and underlying mental 
health issues. These links are not currently well proven or understood.  
 
This study explored correlations between three main variables - economic 
deprivation, depression prevalence and antidepressant prescribing - based on open 
GP prescribing data. The results showed that while there was a strong correlation 
between economic deprivation and antidepressant prescribing, the correlations 
between deprivation and prevalence and between prevalence and prescribing were 
weak. We therefore propose that the hypothesis that depression is a mediating 
factor between deprivation and prescribing is not supported by the available data. 
Moreover, the lack of a clear link between depression prevalence and prescribing 
rates suggest that the clinical basis for increased antidepressant prescribing requires 
further investigation. 
 
Correlations were also explored between deprivation, antidepressant prescribing 
and the prescribing of other drug groups according to BNF Chapter. It can be seen 
from the resulting chart (Fig. 5) that deprivation was strongly correlated with both 
central nervous system (including antidepressants) and endocrine system (including 
insulin) prescribing. Higher levels of antidepressants were correlated with higher 
prescribing levels across multiple drug categories, including cardiovascular system, 
infections, endocrine system and musculoskeletal and joint diseases. 
 
The study also examined the correlation between deprivation, antidepressant 
prescribing and other disease prevalence. This highlighted the link between 
deprivation and prevalence of mental health disorders, as well as chronic obstructive 
pulmonary disease (COPD). It also showed that higher levels of antidepressant 
prescribing tended to occur alongside higher levels of COPD, asthma, diabetes and 
mental health disorders. While the link between antidepressants and mental health 
seems unsurprising, the correlations with COPD, asthma and diabetes may suggest 
opportunities for further research.  
 
One of the things that emerges from the disease prevalence correlation chart (Fig. 
6), is that diabetes seems be connected to a range of other illnesses, including atrial 
fibrillation, hypertension, coronary heart disease and stroke. In terms of 
antidepressant prescribing, the link between diabetes and depression has been well 
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documented in the literature, with some research suggesting that the relationship 
may be bi-directional [10]. This has policy implications in terms of both how diabetes 
might impact depression in the general population, and how the effect of depression 
on self-care, health care usage and expenditure might be addressed [11, 13]. 
4.2 Challenges and limitations 
The major challenges for the study were in identifying, integrating and analysing 
open datasets from diverse sources. Data provided by the public sector in Northern 
Ireland differs in a number of ways from that provided in other parts of the UK, or by 
other nations, which makes valid comparisons more difficult. Specific challenges 
included the use of BNF as opposed to ATC identifiers in prescribing datasets, the 
lack of a formally supported method for linking these two classification systems, 
differences between how prevalence data is collected from other parts of the UK, 
the absence of a standardised method for assigning deprivation measures to GP 
practices, and difficulties in linking GP practice data to geographic boundaries. 
 
The use of British National Foundry (BNF) drug identifiers in the UK caused particular 
challenges due to the lack of an official and comprehensive way of linking these 
codes to the World Health Organisation’s Anatomical Therapeutic Chemical (ATC) 
classification system. This is an important consideration as it is from the ATC system 
that the defined daily doses (DDD) are taken. These DDD values are in turn used to 
compare relative prescription levels across different drug categories. While a NHS-
derived table of correspondences between the two systems is available, it is not yet 
entirely comprehensive, meaning that a small percentage of drugs are not fully 
accounted for in this study.  
  
Finally, this study has only explored data within Northern Ireland, although it reflects 
earlier studies that increases in antidepressant prescribing cannot be explained by 
increases in the incidence of prevalence of depression [19]. Further research is 
required before the findings may be extended to other drug categories, types of 
illness, or other regions. Moreover, since it relied purely on open data, factors such 
as GP gender, which previous research has indicated might be significant [26], have 
not been examined in this study. Generally speaking, there are a range of variables 
which cannot be fully explored in an open data context due to privacy or 
confidentiality considerations.  
4.3 Antidepressant Prescribing and Depression Prevalence 
There has been some exploration within the literature of the validity of using 
pharmaceutical data as a proxy for measuring clinical conditions in a given 
population [8, 9, 16].  The arguments in favour of such an approach include that fact 
that disease prevalence data is often difficult to capture accurately [32], may be 
inconsistently reported [8], and in some cases may not be available at all [9]. In such 
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situations, prescribing data, if available, may offer an attractive alternative for 
studying public health issues. Indeed, some studies have suggested a strong 
correlation between some antidepressants and clinical diagnoses. Gardarsdottir et 
al. [12] for example observed that 73% of patients on an SSRI had a diagnosis of 
depression or anxiety, while Henriksson et al. [14] found that 82% using SSRIs had 
been diagnosed with depression.  
 
While the case for using pharmaceutical data as a tool for public health surveillance 
may seem fairly strong, there are a number of important caveats that should be 
taken into consideration. Firstly, as Henriksson et al. [12] show, not all drugs are 
equally strongly correlated with specific illnesses. Many drugs have more than one 
use, and many antidepressants are used for a wide range of disorders including 
fibromyalgia, chronic pain, eating disorders, insomnia and migraine [12]. An analysis 
by Mercier et al. [23] of antidepressant prescribing among French GPs found that 
20% of prescriptions are potentially unrelated to any psychiatric condition. The 
perceived “safety” of SSRIs may exacerbate the tendency towards prescribing for a 
wider range of conditions [19]. 
 
Our results show that the link between depression prevalence and antidepressant 
prescribing is weak. On the other hand, there does appear to be a strong correlation 
between antidepressant prescribing and prevalence of mental health disorders. This 
suggests that there may be an issue with how patients who receive antidepressants 
are classified - in particular whether they are classified as suffering from either 
depression or from mental health issues. In any case, it is clear that caution must be 
exercised when using prescribing data as in indicator of depression prevalence in the 
wider population. 
4.4 Factors Driving Antidepressant Prescribing 
If, as the data suggests, dramatic increases in the levels of antidepressant prescribing 
are not being motivated by corresponding increases in depression prevalence, the 
question arises as to what other factors might be behind these trends. A number of 
studies have attempted to answer this question by interviewing GPs in order to get 
their perspective on the problem. McDonald et al. [19] propose that few GPs believe 
that depression levels has actually risen, and that there were some concerns about 
whether current prescribing levels were appropriate. When asked to identify factors 
that were driving the increase in prescribing rates, suggestions included: successful 
awareness-raising campaigns on depression, the perceived safety of selective 
serotonin reuptake inhibitors (SSRIs), and a willingness among patients to ask for 
help. Some clinicians believed that normal human “unhappiness” was being 
inappropriately interpreted as a medical condition.  
 
A key finding of our study is that antidepressant prescribing is not strongly 
correlated with depression prevalence, although it is strongly correlated with both 
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mental health issues and diabetes prevalence. This suggests that antidepressants are 
being prescribed to patients diagnosed with other mental health issues. It also 
implies that antidepressant usage is strongly linked to diabetes, which reflects other 
studies on mental health comorbidities in diabetic patients [10]. On the other hand, 
the lack of correlation between antidepressants and depression prevalence once 
raises questions about how patients receiving antidepressants are classified in terms 
of depression and other disease categories. Ultimately, an improved understanding 
of the relationships between diagnosis and prescribing may lead to a better 
explanation of the factors driving antidepressant usage, and of the wider healthcare 
implications of this trend. 
4.5 Clustering Practices Based on Prescribing Patterns and Disease Prevalence 
The clustering of GP practices based on prescribing patterns according to BNF drug 
classifications shows two quite distinct groups based on the overall level of 
prescribing. The group of practices in more deprived areas tended to show higher 
levels of prescribing in all categories except “Malignant Disease”. A three-cluster 
analysis of the same data showed a similar pattern, but effectively partitioned the 
low-deprivation practices into two clusters – a higher prescribing group and a lower 
prescribing group. None of these clusters were characterised by strong differences in 
prescribing for a particular type of drug, but rather by higher or lower prescribing 
levels across all categories. 
 
The second clustering analysis, which used disease prevalence to classify GP 
practices, similarly grouped practices into higher and lower levels of prevalence. 
Interestingly, in the two cluster analysis, there was no clear distinction between the 
clusters in terms of deprivation scores. When the prevalence data was analysed in 
terms of three clusters, the practices were once again split along deprivation lines. 
The GP practices with higher deprivation scores were divided into those with high, 
medium or low prevalence measures across all disease types.  
5 Conclusion 
Mental health has been clearly identified as a priority area for public investment, 
both within Northern Ireland and across the UK as a whole. Policymakers have also 
recognised the need to address effectiveness and efficiency in how these services 
are delivered. The impact of big data on other sectors suggests that data science can 
help to meet some of these needs, although this is an area that is currently under-
explored within the literature. In this study we investigated data analytics might be 
applied to open prescribing data, disease prevalence data and economic deprivation 
data in order to shine a light on public policy and service delivery issues.  
 
Our findings highlight both the limitations and opportunities of such an approach. 
Some widespread assumptions about the value of prescribing data as a proxy for 
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disease prevalence have been called into question. On the other hand, our analysis 
suggests that interesting correlations between disease prevalences and GP 
prescribing do exist, and may have useful implications for future policymaking. 
Moreover, the clustering of GP practices based on depression prevalence data 
implies that different populations respond to economic deprivation factors in 
different ways - an insight that merits further investigation by both researchers and 
policymakers. 
 
The seeming weakness of the correlation between antidepressant prescribing and 
depression prevalence calls into question the medical basis for increasing 
antidepressant usage. Within Northern Ireland, where levels of antidepressant 
prescribing greatly exceed other countries, this is a particularly urgent concern. In 
order to address this problem, further data analysis might be used to identify 
anomalous prescribing patterns and thereby enable targeted interventions by the 
Department of Health. Such analysis could also help to identify hidden 
environmental or clinical factors, and to provide GPs with information to support 
clinical decision-making. 
 
Future research in this area might examine why depression prevalence and 
antidepressant prescribing are so weakly correlated and what the potential 
implications are for public policy. The existence of distinct depression prevalence 
clusters also merits a more detailed investigation. Interviews with GPs and other 
experts might be helpful in order to gain information that is not apparent from a 
purely quantitative analysis. Finally, while this study has focused on the use of open 
datasets, combining these with non-open data about individual GPs and patients 
might allow more granular exploration and provide further policy insights. 
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